SCHEMBL30833891

SCHEMBL30833891

C#Cc1ccc(-c2nnc(N[C@@H]3CCCN(CCO)C3)nc2C)c(OCOCC)c1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 12/20 0.54
IL1B P01584 2/20 0.36
ROCK2 O75116 3/20 0.34
PIK3CD O00329 1/20 0.34
CCNT1 O60563 2/20 0.33
CDK9 P50750 2/20 0.33
CCNK O75909 1/20 0.33
CCNE1 P24864 1/20 0.33
CDK2 P24941 1/20 0.33
CDK12 Q9NYV4 1/20 0.33
DRD2 P14416 1/20 0.33
DRD1 P21728 1/20 0.33
DRD4 P21917 1/20 0.33
DRD5 P21918 1/20 0.33
DRD3 P35462 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30833888 0.92 NLRP3 (0.45) NLRP3IL1BROCK2CCNT1CDK9
SCHEMBL30834010 0.91 NLRP3 (0.44) NLRP3IL1BROCK2PIK3CDCCNT1
SCHEMBL29030496 0.90 NLRP3 (0.41) NLRP3IL1B
SCHEMBL29030501 0.90 NLRP3 (0.41) NLRP3IL1B
SCHEMBL25302189 0.87 NLRP3 (0.55) NLRP3IL1B
SCHEMBL25263725 0.87 NLRP3 (0.55) NLRP3IL1B
SCHEMBL30833904 0.87 NLRP3 (0.38) NLRP3ROCK2CCNKCDK12
SCHEMBL30834001 0.86 NLRP3 (0.62) NLRP3IL1B
SCHEMBL30833882 0.86 NLRP3 (0.38) NLRP3IL1B
SCHEMBL31681910 0.84 NLRP3 (0.44) NLRP3IL1BPIK3CDDRD2DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4613749-A1 NLRP3 INFLAMMASOME INHIBITOR AND USE THEREOF TransThera Sciences (Nanjing), Inc. (CN) 2025-09-10 EP disclosed
CN-117986258-A NLRP3 inflammation corpuscle inhibitor and application thereof 药捷安康(南京)科技股份有限公司 2024-05-07 CN disclosed